Apollon Wealth Management, LLC Chemomab Therapeutics Ltd. Transaction History
Apollon Wealth Management, LLC
- $4.8 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding CMMB
# of Institutions
13Shares Held
2.7MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA941KShares$865,7100.04% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3738KShares$679,0040.24% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3578KShares$532,0270.12% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$196,0070.08% of portfolio
-
Morgan Stanley New York, NY117KShares$107,7870.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $10.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...